Pleasanton, CA 3/27/18—Unchained Labs, which provides solutions for biologics researchers, has purchased Rap.ID for an undisclosed amount. Rap.ID provides systems for particle identification during biopharmaceutical development and QC. The company’s Single Particle Explorer identifies particles by their shape and their chemical and elemental fingerprints. Its Layer Explorer measures the thickness and consistency of silicon oil, which is used to dispense drugs from injectable devices. The company also provides contract services. “These products are great additions to our biologics tools arsenal. We can now help our customers identify the source of any particle that shows up in their process,” stated Unchained Labs Founder and CEO Tim Harkness. “This acquisition expands our portfolio firmly downstream into biologic quality control.” Unchained Labs generates annual revenues of more than $50 million.

Unchained Lab’s sixth acquisition, the transaction was funded in part by a $17 million Series D financing. The Single Particle Explorer systems combines sample preparation, microscopy, image microscopy, and Raman and LIBS analysis. The purchase further adds to Unchained Lab’s focus on analytical instruments for biopharmaceutical QA/QC.